Citi Pharma Shuts Down Rumors of Iraq Expansion

Citi Pharma has officially denied recent media reports suggesting the company is planning to set up a manufacturing facility in Iraq. In a clear and direct statement, the pharmaceutical firm clarified that it has no such intentions at present.

The company emphasized that the reports circulating in various outlets are inaccurate and misleading. Citi Pharma’s management confirmed that while the firm remains committed to exploring strategic growth opportunities, Iraq is not currently part of its expansion roadmap.

This clarification comes amid growing speculation about Pakistani pharmaceutical companies seeking international manufacturing bases. Citi Pharma’s response aims to dispel any confusion and reaffirm its focus on domestic operations and regional priorities.

The company reiterated its commitment to transparency and responsible communication, urging media platforms to verify information before publication. Citi Pharma also assured stakeholders that any future developments will be shared through official channels.

As Pakistan’s pharmaceutical sector continues to evolve, Citi Pharma remains a key player, focused on innovation, quality, and sustainable growth. For now, its sights are set firmly on strengthening its footprint within Pakistan and exploring viable opportunities in neighboring markets—excluding Iraq.

This statement serves as a reminder of the importance of accurate reporting in shaping public perception and investor confidence. Citi Pharma’s swift response underscores its dedication to clarity and strategic focus.